Ron Conway, founder of SV Angel and one of Silicon Valley's most prolific early-stage investors, has disclosed he has a rare form of cancer. Conway announced he is stepping back from his usual activities but will continue supporting founders in the SV Angel portfolio.
The disclosure matters because Conway's fingerprints are on foundational bets in Google, Facebook, Twitter, and hundreds of others. SV Angel has backed over 800 companies. His reduced involvement is not a minor personnel note. It is a signal about the future of one of the Valley's most connected seed funds.
The full piece is worth reading for what Conway did not say: no treatment timeline, no named diagnosis, no succession details for SV Angel. Those gaps are the story.
[READ ORIGINAL →]